Literature DB >> 8568304

The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin.

I Raad1, R Darouiche, R Hachem, M Mansouri, G P Bodey.   

Abstract

The in vitro and in vivo activities of catheters coated with minocycline and rifampin and with chlorhexidine gluconate and silver sulfadiazine were evaluated. When incubated in serum at 37 degrees C, the half-life of the inhibitory activity of catheters coated with minocycline and rifampin was 25 days compared with 3 days for catheters coated with chlorhexidine gluconate and silver sulfadiazine. In a rabbit model, catheters coated with minocycline and rifampin were significantly more efficacious than catheters coated with chlorhexidine and silver sulfadiazine in preventing colonization and infection with Staphylococcus aureus (P < .05). Catheters coated with minocycline and rifampin demonstrated broad-spectrum in vitro inhibitory activity against gram-positive bacteria, gram-negative bacteria, and Candida albicans that was significantly superior to the inhibitory activity of catheters coated with chlorhexidine gluconate and silver sulfadiazine (P < .01). Minocycline and rifampin were also highly efficacious in preventing colonization and infection in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8568304     DOI: 10.1093/infdis/173.2.418

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  30 in total

1.  Catheter-Related Bloodstream Infection.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

2.  Antimicrobial activity of prosthetic heart valve sewing cuffs coated with minocycline and rifampin.

Authors:  Rabih O Darouiche; Vance G Fowler; Karim Adal; Marcia Kielhofner; David Mansouri; L Barth Reller
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

3.  Durability of anti-infective effect of long-term silicone sheath catheters impregnated with antimicrobial agents.

Authors:  R K Tcholakian; I I Raad
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

4.  In vitro potency and in vivo efficacy of a novel bis-indole antimicrobial compound in reducing catheter colonization.

Authors:  Mohammad D Mansouri; Timothy J Opperman; John D Williams; Charles Stager; Rabih O Darouiche
Journal:  Antimicrob Agents Chemother       Date:  2012-01-23       Impact factor: 5.191

Review 5.  Infections associated with medical devices: pathogenesis, management and prophylaxis.

Authors:  Christof von Eiff; Bernd Jansen; Wolfgang Kohnen; Karsten Becker
Journal:  Drugs       Date:  2005       Impact factor: 9.546

6.  Sustained release of antibiotic from polyurethane coated implant materials.

Authors:  Piyali Basak; Basudam Adhikari; Indranil Banerjee; Tapas K Maiti
Journal:  J Mater Sci Mater Med       Date:  2008-07-18       Impact factor: 3.896

7.  In Vitro and In Vivo Effectiveness of an Innovative Silver-Copper Nanoparticle Coating of Catheters To Prevent Methicillin-Resistant Staphylococcus aureus Infection.

Authors:  Myriam K S Ballo; Sami Rtimi; César Pulgarin; Nancy Hopf; Aurélie Berthet; John Kiwi; Philippe Moreillon; José M Entenza; Alain Bizzini
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

8.  Prevention of transmission of multidrug-resistant organisms during catheter exchange using antimicrobial catheters.

Authors:  Mohamed A Jamal; Joel Rosenblatt; Ying Jiang; Ray Hachem; Ann-Marie Chaftari; Issam I Raad
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

9.  Microbicidal activity of a new silver-containing polymer, SPI-ARGENT II.

Authors:  G Kampf; B Dietze; C Grosse-Siestrup; C Wendt; H Martiny
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

10.  Antimicrobial impregnated catheters in the prevention of catheter-related bloodstream infection in hospitalized patients.

Authors:  Sarah K Wassil; Catherine M Crill; Stephanie J Phelps
Journal:  J Pediatr Pharmacol Ther       Date:  2007-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.